After receiving his MSc in Clinical Epidemiology from Stellenbosch University (South Africa) assessing HIV-Metabolic syndrome related risk factors in rural Africa, Dr. Patrick Katoto was awarded the Marc Vervenne Fellowship for his PhD study at KU Leuven (Belgium). His PhD incorporated animal models, clinical-epidemiology and research synthesis approaches to determine the attributable risk of air pollution for pulmonary tuberculosis (TB) among HIV-infected persons, risk factors for chronic cough in TB survivors, and the association between hallmarks of earlier cellular senescence (telomere length/ mtDNA) and TB treatment outcomes among HIV-infected persons. For his NIH-Fogarty Pitt-HRTP-SA postdoc, he is investigating the effect of HIV status on the severity of Pulmonary Hypertension-Left Heart Diseases, in Africa. As part of the Pan African Thoracic Society – Methods in Epidemiologic, Clinical and Operations Research (PATS-MECOR), he completed the three stages, received the 2016 American Thoracic Society (ATS) Foundation MECOR award and currently serves as faculty in the ATS-PATS-MECOR program. Interested on Global Health, he has also completed the advanced certificate in Improving Global Health: Focusing on Quality and Safety from Harvard University (USA).  Dr Katoto is co-investigator on the baseline for sepsis in Africa (Liverpool school of tropical medicine) and the Statin-TB (University of Cape Town) and co-founder of The Centre for Tropical Medicine and Global Health, UCB, D.R. Congo.